324 related articles for article (PubMed ID: 29668066)
1. MAIT cell-mediated cytotoxicity: Roles in host defense and therapeutic potentials in infectious diseases and cancer.
Rudak PT; Choi J; Haeryfar SMM
J Leukoc Biol; 2018 Sep; 104(3):473-486. PubMed ID: 29668066
[TBL] [Abstract][Full Text] [Related]
2. Mucosa-associated invariant T cells in malignancies: a faithful friend or formidable foe?
Haeryfar SMM; Shaler CR; Rudak PT
Cancer Immunol Immunother; 2018 Dec; 67(12):1885-1896. PubMed ID: 29470597
[TBL] [Abstract][Full Text] [Related]
3. MAIT cells launch a rapid, robust and distinct hyperinflammatory response to bacterial superantigens and quickly acquire an anergic phenotype that impedes their cognate antimicrobial function: Defining a novel mechanism of superantigen-induced immunopathology and immunosuppression.
Shaler CR; Choi J; Rudak PT; Memarnejadian A; Szabo PA; Tun-Abraham ME; Rossjohn J; Corbett AJ; McCluskey J; McCormick JK; Lantz O; Hernandez-Alejandro R; Haeryfar SMM
PLoS Biol; 2017 Jun; 15(6):e2001930. PubMed ID: 28632753
[TBL] [Abstract][Full Text] [Related]
4. MAIT cells and microbial immunity.
Meermeier EW; Harriff MJ; Karamooz E; Lewinsohn DM
Immunol Cell Biol; 2018 Jul; 96(6):607-617. PubMed ID: 29451704
[TBL] [Abstract][Full Text] [Related]
5. Mucosa-associated invariant T cells infiltrate hepatic metastases in patients with colorectal carcinoma but are rendered dysfunctional within and adjacent to tumor microenvironment.
Shaler CR; Tun-Abraham ME; Skaro AI; Khazaie K; Corbett AJ; Mele T; Hernandez-Alejandro R; Haeryfar SMM
Cancer Immunol Immunother; 2017 Dec; 66(12):1563-1575. PubMed ID: 28798979
[TBL] [Abstract][Full Text] [Related]
6. Positive & Negative Roles of Innate Effector Cells in Controlling Cancer Progression.
Stolk D; van der Vliet HJ; de Gruijl TD; van Kooyk Y; Exley MA
Front Immunol; 2018; 9():1990. PubMed ID: 30298063
[TBL] [Abstract][Full Text] [Related]
7. Contribution of APCs to mucosal-associated invariant T cell activation in infectious disease and cancer.
Shey MS; Balfour A; Wilkinson KA; Meintjes G
Innate Immun; 2018 May; 24(4):192-202. PubMed ID: 29631470
[TBL] [Abstract][Full Text] [Related]
8. MHC class I-related molecule, MR1, and mucosal-associated invariant T cells.
Franciszkiewicz K; Salou M; Legoux F; Zhou Q; Cui Y; Bessoles S; Lantz O
Immunol Rev; 2016 Jul; 272(1):120-38. PubMed ID: 27319347
[TBL] [Abstract][Full Text] [Related]
9. The Immune Modulating Properties of Mucosal-Associated Invariant T Cells.
Ioannidis M; Cerundolo V; Salio M
Front Immunol; 2020; 11():1556. PubMed ID: 32903532
[TBL] [Abstract][Full Text] [Related]
10. Clinical relevance of circulating mucosal-associated invariant T cell levels and their anti-cancer activity in patients with mucosal-associated cancer.
Won EJ; Ju JK; Cho YN; Jin HM; Park KJ; Kim TJ; Kwon YS; Kee HJ; Kim JC; Kee SJ; Park YW
Oncotarget; 2016 Nov; 7(46):76274-76290. PubMed ID: 27517754
[TBL] [Abstract][Full Text] [Related]
11. Mucosal-Associated Invariant T Cell Interactions with Commensal and Pathogenic Bacteria: Potential Role in Antimicrobial Immunity in the Child.
Ghazarian L; Caillat-Zucman S; Houdouin V
Front Immunol; 2017; 8():1837. PubMed ID: 29326714
[TBL] [Abstract][Full Text] [Related]
12. MAIT cells accumulate in ovarian cancer-elicited ascites where they retain their capacity to respond to MR1 ligands and cytokine cues.
Yao T; Rudak PT; Laumont CM; Michaud AR; Rashu R; Knier NN; Foster PJ; McWilliam HEG; Villadangos JA; Nelson BH; DiMattia GE; Shepherd TG; Haeryfar SMM
Cancer Immunol Immunother; 2022 May; 71(5):1259-1273. PubMed ID: 34854949
[TBL] [Abstract][Full Text] [Related]
13. IL-12 and IL-7 synergize to control mucosal-associated invariant T-cell cytotoxic responses to bacterial infection.
Wallington JC; Williams AP; Staples KJ; Wilkinson TMA
J Allergy Clin Immunol; 2018 Jun; 141(6):2182-2195.e6. PubMed ID: 28870466
[TBL] [Abstract][Full Text] [Related]
14. Human Mucosal-Associated Invariant T Cells in Older Individuals Display Expanded TCRαβ Clonotypes with Potent Antimicrobial Responses.
Loh L; Gherardin NA; Sant S; Grzelak L; Crawford JC; Bird NL; Koay HF; van de Sandt CE; Moreira ML; Lappas M; Allen EK; Crowe J; Loudovaris T; Flanagan KL; Quinn KM; Rossjohn J; Thomas PG; Eckle SBG; McCluskey J; Godfrey DI; Kedzierska K
J Immunol; 2020 Mar; 204(5):1119-1133. PubMed ID: 31988181
[TBL] [Abstract][Full Text] [Related]
15. MAIT Cells Display a Specific Response to Type 1 IFN Underlying the Adjuvant Effect of TLR7/8 Ligands.
Pavlovic M; Gross C; Chili C; Secher T; Treiner E
Front Immunol; 2020; 11():2097. PubMed ID: 33013883
[TBL] [Abstract][Full Text] [Related]
16. Role of MAIT cells in the immunopathogenesis of inflammatory diseases: New players in old game.
Kumar V; Ahmad A
Int Rev Immunol; 2018 Mar; 37(2):90-110. PubMed ID: 29106304
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-18 Is Critical for Mucosa-Associated Invariant T Cell Gamma Interferon Responses to Francisella Species
Jesteadt E; Zhang I; Yu H; Meierovics A; Chua Yankelevich WJ; Cowley S
Infect Immun; 2018 May; 86(5):. PubMed ID: 29507084
[TBL] [Abstract][Full Text] [Related]
18. Classic costimulatory interactions in MAIT cell responses: from gene expression to immune regulation.
Wang NI; Ninkov M; Haeryfar SMM
Clin Exp Immunol; 2023 Jul; 213(1):50-66. PubMed ID: 37279566
[TBL] [Abstract][Full Text] [Related]
19. MAIT cells are critical for optimal mucosal immune responses during in vivo pulmonary bacterial infection.
Meierovics A; Yankelevich WJ; Cowley SC
Proc Natl Acad Sci U S A; 2013 Aug; 110(33):E3119-28. PubMed ID: 23898209
[TBL] [Abstract][Full Text] [Related]
20. Revealing the protective and pathogenic potential of MAIT cells.
D'Souza C; Chen Z; Corbett AJ
Mol Immunol; 2018 Nov; 103():46-54. PubMed ID: 30196233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
